
The Ahamed Lab in the Cardiovascular Biology Research Program is searching for Research Technician to support ongoing research focused on mouse models of heart disease, with a particular emphasis on cardiac fibrosis. We utilize cutting-edge techniques in genetics, molecular biology, cell biology, and biochemistry to explore disease mechanisms and identify potential therapeutic targets. This role offers hands-on experience in experimental research, mouse colony support, and general lab operations within a collaborative scientific environment. Some responsibilities include but are not limited to:
Typically Monday through Friday, between 8:30AM to 5PM with some variables.
Founded in 1946, the Oklahoma Medical Research Foundation (OMRF) is among the nation’s oldest, most respected independent, nonprofit biomedical research institutes. OMRF is dedicated to understanding and developing more effective treatments for human diseases, focusing on critical research areas such as Alzheimer’s disease, cancer, lupus, multiple sclerosis, and cardiovascular disease. OMRF follows an innovative cross-disciplinary approach to medical research and ranks among the nation’s leaders in patents per scientist.
Located in Oklahoma City, a city that offers a dynamic and flourishing downtown area, with low cost of living, short commute times and a diversified economy, OMRF has been voted one of the Top Workplaces since the inception of the award. This achievement has been accomplished thanks to OMRF individuals who share a unified understanding that our excellence can only be fully realized with a collective commitment to our mission, “. . . so that more may live longer, healthier lives.” Successful candidates will demonstrate commitment to this mission.
OMRF is an Equal Opportunity Employer.

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging.
Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF’s critical research is helping people live longer, healthier lives, one discovery at a time.
Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.